SCHEMBL4293769

SCHEMBL4293769

COc1ccc(C(=O)c2c(O)cc(C)cc2OC)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C19 P33261 1/20 0.56
GAA P10253 3/20 0.55
ALDH1A1 P00352 3/20 0.55
NPC1 O15118 2/20 0.54
TUBB4A P04350 1/20 0.54
TUBB P07437 1/20 0.54
TUBA3C P0DPH7 1/20 0.54
TUBA1B P68363 1/20 0.54
TUBA4A P68366 1/20 0.54
TUBB4B P68371 1/20 0.54
TUBB3 Q13509 1/20 0.54
TUBB2A Q13885 1/20 0.54
TUBB8 Q3ZCM7 1/20 0.54
TUBA3E Q6PEY2 1/20 0.54
TUBA1A Q71U36 1/20 0.54
TUBA1C Q9BQE3 1/20 0.54
TUBB6 Q9BUF5 1/20 0.54
TUBB2B Q9BVA1 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7481917 0.90 ALDH1A1 (0.62) CYP3A4CYP2D6CYP2C19GAAALDH1A1
SCHEMBL27707830 0.86 MAPT (0.60) CYP3A4CYP2D6CYP2C19GAAALDH1A1
SCHEMBL4281349 0.83 KMT2A (0.57) CYP3A4CYP2D6CYP2C19GAAALDH1A1
SCHEMBL4283897 0.83 HPGD (0.54) CYP3A4CYP2D6CYP2C19GAAALDH1A1
SCHEMBL4292221 0.83 MEN1 (0.54) CYP3A4CYP2D6CYP2C19GAAALDH1A1
SCHEMBL4283203 0.83 MEN1 (0.47) CYP3A4CYP2D6CYP2C19GAAALDH1A1
SCHEMBL4281069 0.81 CYP3A4 (0.56) CYP3A4CYP2D6CYP2C19GAAALDH1A1
SCHEMBL9726568 0.78 HPGD (0.55) GAAALDH1A1NPC1TUBB4ATUBB
SCHEMBL4279701 0.76 CYP3A4 (0.54) CYP3A4CYP2D6CYP2C19GAAALDH1A1
SCHEMBL29788586 0.76 CYP3A4 (0.68) CYP3A4GAAALDH1A1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 CYP3A4 534/4885CYP2D6 212/4885CYP2C19 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.